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Dendritic cells are professional antigen-presenting cells
that initiate primary immunity. Migration from sites of
antigen uptake to lymphoid organs is crucial for the
generation of immune responses. We investigated the
migratory pathways speci¢cally of epidermal Langer-
hans cells by tracing them from the epidermis to the
draining lymph nodes. This was possible with a new
monoclonal antibody, directed against murine Langer-
in/CD207, a type II lectin speci¢c for Langerhans cells.
In situ, resident, and activated Langerhans cells express
Langerin in the epidermis and on their way through
dermal lymphatic vessels. Both emigrated and trypsini-
zation-derived Langerhans cells expressed high levels of
Langerin intracellularly but reduced it upon prolonged
culture periods. Sizeable numbers of Langerinþ cells
were found in skin draining lymph nodes but not in
mesenteric nodes. Langerinþ cells localized to the
T cells areas and rarely to B cell zones. Numbers of
Langerin-expressing cells increased after application of
a contact sensitizer. In the steady state, Langerhans cells
in the skin-draining nodes expressed maturation mar-
kers, such as 2A1 and costimulatory molecules CD86
and CD40. These molecules, CD86 and CD40, were
further upregulated upon in£ammatory stimuli such as
contact sensitization. Thus, the novel anti-Langerin
monoclonal antibody permits the unequivocal visuali-
zation of migratory Langerhans cells in the lymph
nodes for the ¢rst time and thereby allows to dissect
the relative immunogenic or tolerogenic contributions
of Langerhans cells and other types of dendritic cells.
Key words: cell tra⁄cking/dendritic cells/in£ammation/skin/
spleen and lymph nodes. J Invest Dermatol 120:266 ^274,
2003
D
endritic cells are the only antigen-presenting cells
that are able to initiate primary immune responses
(Banchereau and Steinman, 1998). Their functional
spectrum comprises antigen uptake and processing
capacities (Mellman and Steinman, 2001), which
are exerted mostly in peripheral organs and tissues, as well as na-
ive and memoryT cell sensitizing skills, which are performed in
the lymphoid organs. To ful¢ll these tasks they need to be highly
motile to bridge the sites of antigen uptake and the sites of T cell
stimulation. Emigrating cutaneous dendritic cells carry major
histocompatibility complex (MHC)^antigenic peptide complexes
on their cell surfaces and present them toT cells in the lymphoid
organs (Austyn, 1996; Steinman et al, 1997; Flores-Romo, 2001).
Emigration is induced by in£ammatory cytokines, such as tu-
mor necrosis factor-a and interleukin-1b (Cumberbatch et al,
1997; Stoitzner et al, 1999) and further modi¢ed by chemotactic
agents, such as MIP-3b/CCL19 (Kellermann et al, 1999), SLC/
CCL21 (Saeki et al, 1999), and interleukin-16 (Stoitzner et al,
2001).When infectious agents invade the peripheral tissue in£am-
matory mediators are produced by diverse skin cells. They induce
the detachment of Langerhans cells from neighboring keratino-
cytes, most probably by downregulation of E-cadherin (Schwar-
zenberger and Udey, 1996). The released Langerhans cells are able
to leave the epidermal compartment and passage the basement
membrane possibly by secreting matrix metalloproteinases and
digesting the dense collagen meshwork of the epidermal^dermal
junction (Kobayashi et al, 1999; Ratzinger et al, 2002). With the
help of di¡erent adhesion molecules, e.g., a6 integrins (Price
et al, 1997) and CD44 (Weiss et al, 1997), and enzymes for diges-
tion of the extracellular matrix (Ratzinger et al, 2002), dendritic
cells migrate further through the dermis until they encounter
lymphatic vessels (Larsen et al, 1990; Lukas et al, 1996; Weinlich
et al, 1998; Stoitzner et al, 2002). Skin explant culture (Larsen
et al, 1990) and contact hypersensitivity models (Enk et al, 1993)
have been widely used to investigate morphologic and regulatory
aspects of dendritic cell migration.Therefore, we used both mod-
els to trace Langerhans cells through the skin into the draining
lymph node by means of new monoclonal antibodies (MoAb)
that recognize the murine homolog of the human type II lectin
Langerin (CD207) (Valladeau et al, 2002). This molecule is ex-
pressed on the cell surface and in Birbeck granules, which are
the hallmark of Langerhans cells. Langerin appears to be a key
structural element in Birbeck granule formation and presumably
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facilitates the uptake of mannans on the cell surface of bacteria
(Valladeau et al, 1999, 2000).
Several recent reports attempted to identify migratory Langer-
hans cells in the skin draining lymph nodes. Salomon et al (1998)
described two CD11cþ MHC class IIþ cell populations in skin
draining lymph nodes. One population was comprised of large
cells that expressed a mature phenotype and most of the cells
were positive for £uorescein isothiocyanate (FITC) after skin
painting, thus mostly likely representing immigrated Langerhans
cells from the periphery. The other dendritic cell population was
smaller in size and segregated into two groups, a CD4þ -mye-
loid-derived and a CD8aþ -lymphoid-related one, which took
up intravenously injected FITC and had a more rapid turnover.
Ruedl et al (2000) reported a CD11chighCD40high population in
the lymph node that showed some characteristics of Langerhans
cells. They were strongly MHC class IIþ , expressed E-cadherin,
contained a few Birbeck granules and had a long turnover rate in
contrast to the other lymph node populations. Additionally, they
transported £uorescent tracer from the epidermis to the lym-
phoid tissue. Henri et al (2001) described a DEC-205/CD205high,
CD8a^, MHC class IIhigh population in skin draining lymph
nodes, which also expressed high levels of CD40, CD11c, and
Langerin, and transported a £uorescent tracer to the lymphoid
tissue. We attempted to de¢ne further and characterize these
lymph node populations as well as the ¢rst part of the migratory
pathway within the skin by means of novel tools, i.e., Langerhans
cell-speci¢c anti-mouse Langerin/CD207 antibodies (Valladeau
et al, 2002).
MATERIALS AND METHODS
Mice Mice of inbred strains C57BL/6 and BALB/C were purchased from
Charles River Germany (Sulzfeld, Germany) and used at 3^12 mo of age.
Langerin reagents Several di¡erent antibodies against mouse Langerin
were used [HD26, mouse IgG1, and a rabbit immune serum for
preliminary experiments only; HD24, mouse IgG1 (Valladeau et al, 2002)
and 929F3, rat IgG1]. The di¡erent anti-Langerin MoAb gave identical
staining results, both in terms of staining intensity and staining patterns.
The anti-Langerin MoAb 929F3 was also available in FITC- and biotin-
conjugated forms.
Transfection of COP5 ¢broblasts for control of antibody
speci¢city Transfections were performed by electroporation of the
mouse Langerin cDNA (Valladeau et al, 2002) into the murine ¢broblastic
COP5 cell line (Tyndall et al, 1981). Cells transfected with an empty
plasmid served as mock controls.
Skin explant culture Culture medium was RPMI-1640 supplemented
with 10% fetal bovine serum, gentamycin (all from PAA, Linz, Austria),
and 2-mercaptoethanol (Sigma, St Louis, MO). Mice were killed and ears
were cut o¡ at the base. Ear skin was split in dorsal and ventral halves by
means of strong forceps and the dorsal halves (i.e., cartilage-free halves)
were cultured in 24-well tissue culture plates (one ear per well) as
described (Ortner et al, 1996; Romani et al, 1997; Weinlich et al, 1998).
Alternatively, epidermis and dermis were separated from each other by
means of the bacterial enzyme dispase (Boehringer Mannheim,
Mannheim, Germany) (Kitano and Okado, 1983), and the epidermal
sheets were placed in culture. In most experiments whole skin, epidermis,
and dermis were cultured continuously for 48 h. Cells that had emigrated
from the explants were collected, counted, and further evaluated
phenotypically.
Induction of contact sensitization Murine ear skin was painted with
15 ml 1% 2,4,6-trinitro-1-chlorobenzene (TNCB), picryl chloride (Kodak
Eastman, Rochester, NY) on the dorsal and ventral sides. After 24 and 48
h epidermal and dermal sheets were prepared. For this purpose, the skin
was £oated dermal side down on 0.5 M ammonium thiocyanate for 20
min at 371C. The epidermis was peeled o¡ the dermis and both parts
were cut into 55 mm pieces and ¢xed in acetone for 20 min.
Immunohistochemistry of epidermal and dermal sheets Epidermal
and dermal sheets were incubated overnight at 41C with anti-Langerin
MoAb (HD24 and 929F3). Antibodies were visualized by using
biotinylated anti-mouse and anti-rat immunoglobulin, respectively, and
streptavidin-FITC or streptavidin-Texas Red (all from Amersham Life
Science, Amersham, U.K.; 90 min at 371C). Dendritic cells were
counterstained with anti-I-A/Ediverse (clone 2G9, £uoresceinated, rat
IgG2a; BD-Pharmingen, San Diego, CA). Specimens were viewed on a
conventional Olympus epi£uorescence microscope.
Isolation of Langerhans cells and dermal dendritic cells from
murine skin Epidermal cells were isolated by standard trypsinization
(JHR-trypsin from Sera-lab, Crawley Down, West Sussex, U.K.) (Koch
et al, 2001) and dermal cells after removal of the epidermis and thorough
rinsing by digestion in 0.5 mg per ml collagenase P (Roche Applied
Science, Hamburg, Germany) for 30^60 min at 371C. Both cell
populations were either analyzed by £uorescence-activated cell sorter
(FACS) immediately or cultured for 3^4 d in Iscove’s medium (Pan,
Hamburg, Germany) supplemented with 10% fetal bovine serum and 200
U per ml murine granulocyte-macrophage colony-stimulating factor using
supernatants of a transfected cell line as the source of cytokine (kindly
provided byA. Lanzavecchia, Bellinzona, Switzerland).
Preparation of lymph node cell suspensions Cell suspensions from
lymph nodes were obtained by digestion with 0.5 mg per ml collagenase
P (Roche) for 30 min at 371C and subsequent pressing the tissue through
steel sieves, essentially as described recently for spleen cell suspensions
(McLellan et al, 2002). For some experiments, dendritic cells were
enriched by Nycodenz gradient centrifugation (Sigma-Aldrich, Vienna,
Austria) as described (McLellan et al, 1995).
Phenotype of Langerhans cells and dermal dendritic cells isolated
from skin or lymph nodes Cells were ¢xed and permeabilized with a
kit (Fix & PermTM) from BD-Pharmingen and stained in sequence with
the rat IgG anti-Langerin 929F3 MoAb or an irrelevant rat IgG as control
(Jackson Immuno Research Laboratory, Avondale, PA), anti-rat
immunoglobulin-phycoerythrin (BD-Pharmingen), an excess of rat IgG
(100 mg per ml) for blocking residual free antibody binding sites, and
counterstained either with anti-MHC class II (clone 2G9), anti-CD86
(clone GL1), or anti-CD40 (clone 3/23) (all FITC conjugated and from
BD-Pharmingen). Nycodenz-enriched cell populations were used for
analyses of lymph node cells.
Detection of emigrated Langerhans cells in skin draining lymph
nodes after contact allergen sensitization Mice were sensitized with
200 ml (abdomen) or 15 ml (ears) 1% TNCB on both sides. After 24 h,
single cell suspensions were prepared from skin draining lymph nodes
(auricular and inguinal). Cytocentrifuge smears were prepared from these
cell suspensions, as mentioned above and counterstained with 406-
diamidino-2-phenyindole (DAPI) for visualization of nuclei. Langerinþ
cells were counted under the microscope using  40 objective lenses and
a calibrated grid (at least 20 ¢elds). Alternatively, cells from skin draining
lymph nodes (auricular and inguinal) were analyzed by FACS.
Immunohistochemistry of lymph node sections
Single enzyme labeling Skin draining (inguinal or auricular) lymph nodes
of untreated mice were frozen and cut into 10 mm sections on a cryostat
(Frigocut, Leitz,Vienna, Austria).The sections were brie£y ¢xed in acetone
and stained with anti-Langerin (929F3), anti-CD8 (clone TIB105, rat
IgG2b), anti-CD45R (B220, TIB146, rat IgM), and irrelevant isotype-
matched control rat immunoglobulin. Antibody binding was detected by
alkaline phosphatase-conjugated anti-rat immunoglobulin F(ab)2 frag-
ments (Jackson). CD3 (clone 2C11, hamster immunoglobulin) was detected
by a biotinylated anti-Syrian and Armenian hamster immunoglobulin
(BD-Pharmingen) followed by alkaline phosphatase-conjugated streptavi-
din (Jackson).The enzyme was visualized withVector-Blue and nuclei were
counterstained with Nuclear-Fast-Red (both from Vector Laboratories,
Burlingame, CA).
Double enzyme labeling Serial frozen 5 mm sections were placed on to
3-amino-propyltriethoxy-silane (Sigma) coated slides, air-dried overnight,
¢xed in acetone for 10 min, rehydrated in Tris-bu¡ered saline and blocked
in 5% goat and 5% rabbit serum inTris-bu¡ered saline for 5 min. Sections
were incubated in sequence either with rat anti-CD19 and horseradish per-
oxidase-rabbit anti-rat immunoglobulin (DAKOCytometrics, Glostrup,
Denmark) or with hamster anti-CD3, biotinylated-goat anti-hamster im-
munoglobulin (Jackson), and horseradish peroxidase-labeled streptavidin
(Sigma). A brown color was revealed by application of the substrate diami-
nobenzidine.The second MoAb, rat anti-Langerin (929F3) was followed by
horseradish peroxidase-rabbit anti-rat immunoglobulin (DAKO). The sec-
ond enzyme reaction was developed using Histogreen, giving a blue^green
color. Sections were counterstained with hematoxylin and embedded in
organic mounting media (Vitro-Clud, Langenbrink, Germany).
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Double immuno£uorescence labeling In some experiments sections were
stained with the maturation marker 2A1 [clone 2A1, rat IgG2a, R.M.
Steinman, NY (Inaba et al, 1992; Steinman et al, 1997)] followed by FITC-
conjugated anti-rat immunoglobulin (BD-Pharmingen). After blocking
residual free antibody binding sites with an excess of rat immunoglobulin
(100 mg per ml) counterstaining was done with a biotinylated rat anti-
mouse Langerin MoAb (929F3) and streptavidin-Texas Red.
Statistics Appropriate statistic tests (t-test, one-way ANOVA) were chosen
and used to analyze data and to determine whether the di¡erences between
the results were signi¢cant.
RESULTS
Speci¢city of novel anti-Langerin/CD207 antibodies
Speci¢city of MoAb HD24 against murine Langerin was shown
on mouse Langerin-transfected COP ¢broblasts (Valladeau et al,
2002). Other anti-Langerin antibodies were generated by
immunization of rats and the speci¢city of the particular rat
MoAb used in this study (929F3) is shown in Fig 1. Langerin-
transfected ¢broblasts stained clearly with the 929F3 MoAb in
contrast to mock-transfected cells as analyzed by FACS (Fig 1).
Langerhans cells express Langerin in the steady state in the
skin MoAb against mouse Langerin speci¢cally stain
Langerhans cells. This is best visualized in epidermal sheets as
¢rst shown by Valladeau et al (2002). Here, we con¢rm that
virtually all Langerhans cells, as identi¢ed by their MHC class II
expression, display strong Langerin reactivity in intracellular
granular structures. Inversely, all Langerinþ cells expressed
MHC II (Fig 2A). In native dermis we observed only some rare
Langerinþ cells, possibly Langerhans cells in transit (data not
shown).
Migratory Langerhans cells express Langerin in situ Murine
skin explants were cultured for 48 h and epidermal and dermal
sheets were prepared for immunohistochemistry at the end of
the culture period. Inspection of epidermal sheets con¢rmed the
previously described phenomenon (Larsen et al, 1990; Lukas et al,
1996; Weinlich et al, 1998): the density of Langerhans cells
remaining in the epidermis was greatly reduced. The few
remaining Langerhans cells appeared activated by their strongly
increased MHC class II expression. They uniformly expressed
Langerin at a staining intensity indistinguishable to that of
Langerhans cells in untreated epidermis (Fig 2B). The
corresponding dermal sheets showed migratory dendritic cells in
‘‘cords’’ (Larsen et al, 1990), i.e., string-like accumulations of
strongly MHC class IIþ cells. Approximately 60% of the MHC
class IIþ cells in the ‘‘cords’’ expressed Langerin (Fig 2C),
indicating that they were Langerhans cells from the epidermis.
Langerin staining was predominantly intracellular. This
percentage varied to a large extent from ‘‘cord’’ to ‘‘cord’’. The vast
majority of migrating dendritic cells were mature as determined
by two criteria. First, even conventional £uorescence microscopy
revealed the prominent cell surface localization and the absence
of intracellular MHC II molecules, which may be regarded as a
sign of maturation (Pierre et al, 1997). Secondly, and more
speci¢cally, most emigrating Langerinþ Langerhans cells in the
‘‘cords’’coexpressed the maturation marker 2A1 (Fig 2E,F).
Migratory Langerhans cells express Langerin in vivo An
in£ammatory situation in the skin in vivo was induced by the
epicutaneous application of the contact allergen TNCB. After 24
h only few lymph vessels ¢lled with emigrating cutaneous
dendritic cells were visible. ‘‘Cords’’ were more pronounced after
48 h, albeit to a lesser degree as compared with the skin explant
culture model. Again, a large part of the migratory cells were
Langerhans cells as de¢ned by their marked expression of
Langerin (Fig 2D).
Origin and phenotype of dendritic cells that emigrate out of
skin explants As opposed to the human system (Lenz et al,
1993; Larregina et al, 2001) it has not been possible so far to draw
an unequivocal distinction between Langerhans cells and dermal
dendritic cells that migrate from murine whole skin explants.We
therefore used Langerin antibodies to analyze dendritic cells that
had ‘‘crawled out’’ from murine whole skin explants over a period
of 48 h. Double-labeling of cytospins revealed that virtually all
Langerin-expressing cells were also strongly MHC class IIþ and
expressed the maturation marker 2A1 (Inaba et al, 1992) (data not
shown). Conversely, however, not all MHC class IIþ cells were
anti-Langerin reactive. Control specimens of emigrant dendritic
cells from epidermal sheets that had been obtained by dispase
treatment before the onset of culture, were virtually all
Langerinþ (Fig 3A). Dendritic cells from the corresponding
dermal sheets were largely Langerin^ (Fig 3A), yet, a substantial
subpopulation of Langerinþ dendritic cells was consistently
found. As expected, dendritic cells from whole skin explants
represented a mixture of Langerinþ (i.e., Langerhans cells) and
Langerin^ (i.e., dermal dendritic cells) MHC class IIþ cells
(Fig 3A). Both populations occurred in approximately equal
proportions, Langerhans cells being slightly more frequent. A
mean of 62% of all MHC class IIþ cells coexpressed Langerin
on cytospins. By FACS, similar percentages of intracellularly
Langerinþ cells were determined for populations of dendritic
cells (i.e., MHC class IIþ cells) emigrated from dispase-procured
epidermal sheets, corresponding dermal sheets and from whole
skin explants (Fig 3B). In preparations of dermal cells isolated
by collagenase digestion of native dermis we found that an
average of 10% of the MHC class II-expressing cells were
positive for Langerin (Fig 3C). Interestingly, after a culture
period of 2 d the proportion of Langerin-expressing cells in the
MHC class IIþ fraction rose signi¢cantly over 50% and
decreased afterwards.
Retention of Langerin in Langerhans cells during
maturation Based on its speci¢city it is tempting to use
Langerin as a tracer for Langerhans cells from the epidermis. Yet,
Langerin is endocytosed quickly after antigen uptake (Valladeau
Figure1. The new rat MoAb (929F3) is speci¢c for Langerin. Fibro-
blasts were transfected either with a mock gene or the mouse Langerin
gene. In FACS analyses the new MoAb 929F3 stained speci¢cally the Lan-
gerin-transfected cells (right panel) and not the control cells (left panel).Thin
line, isotype control; bold line, Langerin staining.
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et al, 1999) and is downregulated upon Langerhans cell culture
(Valladeau et al, 2002). Birbeck granules disappear at the
ultrastructural level (Schuler and Steinman, 1985). We therefore
wondered for how long Langerhans cells, that were generated
by di¡erent isolation procedures, would express Langerin.
Emigrated Langerhans cells obtained by epidermal explant
culture and Langerhans cells isolated by trypsinization of native
epidermis and cultured together with keratinocytes were stained
side by side for Langerin and MHC II and analyzed on cytospins
or by FACS. On cytospins, migratory Langerhans cells identi¢ed
by their MHC II expression, retained Langerin expression during
4 d of skin explant culture and only few Langerhans cells
completely lost their Langerin expression (data not shown).
Cytospins of day 4 Langerhans cells obtained by trypsinization
of native epidermis showed a more pronounced decrease in
Langerin expression with more cells actually losing anti-
Langerin reactivity, as described by Valladeau et al (2002). Time-
course experiments were evaluated by more sensitive FACS
analyses. We observed a decrease in intracellular Langerin
staining intensity in the Langerhans cells generated both ways
(Fig 4) with a more pronounced reduction in the Langerhans
cells obtained by trypsinization.
Langerhans cells can be detected in the T cell area of skin
draining lymph nodes in the steady state As intracellular
Langerin expression is retained in migratory Langerhans for
some time, we used it as a Langerhans cell tracer molecule and
searched for Langerinþ cells in the lymph nodes. Langerin-
Figure 2. Langerin is expressed in resident and migrating Langerhans cells. In epidermal (rows A, B) and dermal sheets (rows C, D, E + F), Langer-
hans cells were stained with anti-Langerin HD24 MoAb (middle column) and with anti-MHC class II (left column) or the maturation marker 2A1 as indicated.
Double exposures of both colors are depicted in the right column. Langerin is expressed in all MHC class II+ cells, i.e., Langerhans cells, in both native (A) and
cultured (B) epidermis. About 60% of migrating MHC class II+ cells in the lymphatic vessels in the dermis express Langerin (C). In an in vivo in£ammatory
situation after application of contact allergen lymphatic vessels also contained Langerin (929F3 MoAb)/MHC class II-double positive cells (D). Almost all
Langerin+ cells (green £uorescence in E, F; using a FITC-conjugated 929F3 anti-Langerin) in the lymphatic vessels expressed the maturation marker 2A1
(red £uorescence in E, F). Mature, Langerin^ cells, i.e., migrating dermal dendritic cells are marked with arrowheads. Isotype controls were always clearly
negative. Scale bar ¼ 20 mm for all pictures.
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expressing cells can be found in skin draining lymph nodes from
untreated mice as recently shown by Henri et al (2001). Therefore,
we ¢rst compared Langerin expression in skin-draining vs
mesenteric lymph nodes of untreated mice. Lymph node cells
were prepared, enriched for dendritic cells by a Nycodenz
gradient, stained for Langerin and analyzed by FACS.We found
a signi¢cant population of Langerinþ cells in skin draining
lymph nodes (Fig 5A). By contrast, in mesenteric lymph nodes
only very few Langerinþ cells occurred (Fig 5A). By
immunohistochemistry of lymph node sections this di¡erence
was con¢rmed in that much higher numbers of Langerin-
expressing cells were visible in the skin-draining nodes than in
the mesenteric lymph nodes (Fig 5B).
To locate more precisely these migratory skin dendritic cells in
situ, we stained sections of skin draining lymph nodes of
untreated mice with anti-Langerin and markers that de¢ne the T
and B cell areas (CD3 for T cells and CD45R/B220 for B cells).
Langerinþ cells were found in theTcell areas. By contrast, B cell
follicles did not harbor Langerin-reactive cells in general but
rarely a few cells could be observed (Fig 6a^c). On consecutive
sections CD11c and CD205/DEC-205 localized to the same areas
(data not shown). To underscore these ¢ndings we conducted
double-labeling of lymph node sections. Langerin-expressing
cells colocalized with CD3þ T cells (Fig 6d) but were excluded
from B cell areas (de¢ned by anti-CD19 labeling) (Fig 6e).
Increased numbers of Langerhans cells can be detected
in the skin draining lymph nodes after contact
sensitization Next, we investigated Langerin expression in
skin draining lymph nodes 24 h after application of a contact
sensitizer (1% TNCB) to abdominal and ear skin. Cytospins of
unenriched suspensions of lymph node cells were prepared and
stained for Langerin. In lymph nodes from control mice that
had been treated with the vehicle only (acetone/olive oil) few
Langerinþ cells were detected by immuno£uorescence
microscopy. The numbers of Langerinþ cells per inguinal
lymph node in vehicle-treated mice was on average 486072700.
In inguinal lymph nodes from sensitized animals the number
Figure 3. Origin of migratory skin dendritic cells. From skin explant
cultures of epidermis, dermis, and whole skin, cutaneous dendritic cells
emigrated into the medium during a 48 h incubation. (A) Emigrated cells
were double labeled for Langerin and MHC class II on cytospins and dou-
ble-positive cells were scored (mean 7 SD, n ¼ 4, npo0.01, nnpo0.001).
(B) By FACS, these migratory cells were double labeled for Langerin and
MHC class II and analyzed (one representative experiment of at least three).
Nearly all epidermal cells were double positive for both markers (left panel)
in contrast to the dermal cells (middle panel). Mixed populations of Langer-
hans cells and dermal dendritic cells emigrated from complete skin (right
panel). (C) Dermal cells were prepared by collagenase digestion and cul-
tured up to 3 d stained with anti-Langerin and MHC class II MoAb. By
FACS Langerin+ cells of all MHC class II expressing cells were determined
and are presented in percent (mean7SD, n¼ 5, npo0.001). An increase in
Langerin+ cells in the dendritic cell population in the dermis could be best
observed after 2 d of culture. For all experiments we used 929F3 MoAb.
Figure 4. Loss in intensity of Langerin expression in Langerhans
cells during prolonged culture periods. Langerhans cells were gener-
ated either by trypsinization of the epidermis and subsequent culture for
4 d (upper panels) or by migration out of epidermal sheets during 4 d (lower
panels). Cells were double labeled for Langerin (929F3 MoAb) and MHC
class II and analyzed by FACS. This experiment is representative of four
independent experiments.
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of Langerin-expressing cells increased up to an average
54350722960 (Fig 7A) thus inducing an 11-fold increase in
immigrated Langerhans cells. In FACS analyses of skin draining
lymph node cells (auricular and inguinal) from vehicle- or
TNCB-treated mice we observed a pronounced increase in the
percentages of Langerinþ cells (Fig 7B). When these
percentages were multiplied with the total cell numbers
obtained in the hemocytometer we observed again a rise in
absolute Langerhans cell numbers in skin draining lymph nodes
after TNCB application (Fig 7C); however, this was not as
pronounced, which may be explained by the di¡erent
experimental settings.
Phenotype of Langerinþ cells in skin draining lymph
nodes Langerinþ cells in the nodes of untreated mice were
further analyzed, particularly with regard to their state of
maturation. Cells were isolated from skin draining lymph nodes,
enriched for dendritic cells with a Nycodenz-gradient. CD11cþ
and CD11c^ cell populations were analyzed for Langerin and
MHC class II expression by FACS. No Langerin staining was
found in the CD11c^ fraction emphasizing the speci¢city of
Langerin for dendritic cells. All Langerin-expressing cells were
detectable in the CD11cþ fraction representing lymph node
dendritic cells. Furthermore, Langerinþ cells expressed high
levels of MHC class II, which has been described to be a marker
for migratory Langerhans cells in skin draining lymph nodes
(Ruedl et al, 2000; Henri et al, 2001) (Fig 8a). Almost all
migrating Langerinþ cells in the lymphatic vessels of the skin
expressed the maturation marker 2A1 (Fig 2E,F). We were
therefore interested whether the Langerinþ cells that arrive in
the lymph node in the ‘‘steady state’’ were already mature.
Indeed, by immuno£uorescence on lymph node sections we
noted that most, but not all, Langerinþ cells coexpressed
the maturation marker 2A1 (Fig 8b). Thus, a distinct minor
Figure 5. Langerin+ cells are found in skin draining lymph nodes.
(A) Cells from skin-draining and mesenteric lymph nodes were isolated,
enriched on a Nycodenz-gradient and stained for Langerin. In skin drain-
ing lymph nodes (left panel) we found substantial numbers of Langerin+
cells in contrast to mesenteric lymph nodes (right panel). Langerin staining
bold line, isotype staining, dashed line. One representative experiment of
three is shown. (B) By immunohistochemistry high numbers of Langerin+
cells (blue color) can be appreciated in an auricular node (left panel) but only
few scattered Langerin+ cells in a mesenteric node (right panel). One repre-
sentative experiment of three is shown. Panel B, original magni¢cation 
60. For all experiments we used 929F3 MoAb.
Figure 6. Langerin+ cells localize to theTcell areas of skin draining
lymph nodes. Lymph node sections were immunolabeled to determine
the localization of Langerin+ cells (929F3 MoAb). On consecutive sections
(top row) it becomes apparent that Langerin+ cells (b) are in theTcell area as
de¢ned by anti-CD3 reactivity (c) but not in the B cell follicles as de¢ned
by B220 labeling (a). Double labeling of Langerin (blue cells) and CD3 (d)
and CD19 (e) (brown cells) con¢rms the mutual exclusion of B cells and
Langerin-reactive cells (e). Original magni¢cation: (a^c)  40; (d,e) 
240.
Figure 7. Increased numbers of Langerin+ cells in skin draining
lymph nodes after contact sensitization with TNCB. Mice were trea-
ted with the contact sensitizer TNCB or vehicle (acetone/olive oil) on the
shaved abdominal or ear skin. After 24 h skin draining lymph node cells
were prepared and stained for Langerin (929F3 MoAb). (A) On cytospins,
nuclei were counterstained with DAPI and the Langerin+ cells were
counted (mean7SD, n¼ 5, npo0.001). (B) By FACS, the percentage of
Langerin+ cells in total lymph node suspensions was determined. One re-
presentative experiment of 11. (C) Absolute numbers of Langerhans cells
determined by relating FACS-derived percentages with hemocytometer
counts (mean7SD, n¼11, npo0.0001).
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(o 3% of Langerinþ cells) subset of immature (i.e., 2A1)
Langerhans cells was consistently detected in the lymph nodes.
FACS analyses con¢rmed that almost all Langerinþ cells in the
skin draining lymph node coexpressed the costimulatory
molecules CD86 and to a lesser extent CD40 (Fig 8c). For
comparison, we induced a strong in£ammation in the skin by
epicutaneous application of the contact allergen TNCB and
examined the maturation state of immigrated Langerhans cells
in the skin draining lymph nodes 24 and 48 h thereafter. We
observed a slight but consistent increase in cells coexpressing
Langerin and CD86 or Langerin and CD40; however, this was
not statistically signi¢cant (Fig 8c). Additionally, the intensity of
these two costimulatory molecules on Langerinþ cells in the
lymph nodes was consistently enhanced after application of
contact allergen (Fig 8d).
DISCUSSION
Until now, the hallmark for murine Langerhans cells was the ten-
nis-racket-shaped Birbeck granule that could only be visualized
by transmission electron microscopy (Birbeck et al, 1961; Wol¡,
1967; Hashimoto, 1971). Langerin/CD207, a type II transmem-
brane protein belonging to the family of Ca2þ -dependent
(C-type) lectin receptors, was identi¢ed as a main molecular
component of Birbeck granules, ¢rst in humans (Valladeau et al,
1999, 2000) and then in the mouse (Valladeau et al, 2002). The
development of monoclonal anti-mouse Langerin antibodies
(Valladeau et al, 2002) made it possible for the ¢rst time to trace
murine Langerhans cells along their migration pathway.We show
here that Langerhans cells express Langerin during the entire mi-
gration process from the epidermis through lymphatic vessels
into the lymph nodes.
Origin of dendritic cells emigrating out of whole skin
explants Novel anti-mouse Langerin MoAb (Valladeau et al,
2002) make it possible for the ¢rst time to determine the relative
proportions of Langerhans cells and dermal dendritic cells in
murine whole skin explant cultures. As expected, dendritic cells
‘‘crawling out’’ from epidermal sheets are virtually all Langerinþ ,
and dendritic cells originating from dermal sheets are largely
Langerin^. Still, surprisingly many Langerinþ cells occurred in
the dermal emigrant populations as compared with human
dermal populations where this percentage rarely exceeded 5% of
all dendritic cells (Lenz et al, 1993). This is in contrast to the
¢nding that immuno£uorescence of native dermis revealed only
few scattered Langerinþ cells. One explanation for this
discrepancy might be the minute pieces of epidermis that
inevitably adhere to the dermal sheet after dispase separation or
hair follicles as observed by histologic hematoxylin and eosin
staining. Another source for Langerinþ Langerhans cells in the
dermis could be emigrating Langerhans cells already on their
way out of the skin in the steady state, but one might not
expect such high numbers. A further possibility is that
Langerinþ cells in the dermal preparations are immigrating
Langerhans cell precursors, expressing already MHC class II but
not yet Langerin. They would develop into Langerin-expressing
cells during the emigration out of the dermal explants. This
possibility is underscored by our observation that dermal cell
suspensions isolated by enzymatic digestion and cultured for 2 d
contained over ¢ve times more Langerinþ cells as compared
Figure 8. Phenotype of Langerin+ cells in skin draining lymph
nodes. (a) Skin draining lymph node cells were isolated, enriched with a
Nycodenz-gradient, and analyzed by FACS for MHC class II and Langerin
expression. Langerin+ cells were only found in the CD11c+, i.e., dendritic
cell fraction and expressed high levels of MHC class II. (b) Double labeling
of skin draining lymph node sections with the maturation marker 2A1
(green £uorescence) and Langerin (red £uorescence) shows that nearly all
Langerin+ cells are mature (yellow £uorescence in A). (A) Overview,
double exposure. Some mature non-Langerhans cells are marked with
arrowheads, (B,C) Same ¢eld, single labeling. Higher magni¢cation of
2A1 (E), Langerin (F), and overlap (D). Scale bars: (A) 50 mm; (B,C) 100
mm; (D^F) 20 mm. (c) Skin draining lymph node cells were enriched with
a Nycodenz-gradient and examined for expression of costimulatory mole-
cules CD86 and CD40. A high percentage of Langerin+ cells expressed
these markers and numbers increased after induction of a contact hypersen-
sitivity reaction (mean7SD, n¼ 5). (d) By FACS analysis an increase in
intensity of CD86 (left panel) and CD40 (right panel) expression was ob-
served in TNCB-treated mice (bold line) in contrast to untreated mice (thin
line). Dotted lines are isotype controls. One representative experiment of
¢ve is shown. For all experiments we used 929F3 MoAb.
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with the onset of culture. Such a precursor population migrating
out of human skin explants expressing CD14þ and Langerin has
been described by Larregina et al (2001); however, preliminary
experiments did not reveal the presence of CD14þ cells in
freshly isolated dermal cell suspensions.
Langerhans cells can be traced to the draining lymph nodes
by their Langerin expression As Langerin is expressed
intracellularly in Langerhans cells for quite a long time, we were
able to track migrating Langerhans cells to their destination in
the lymphoid organs. Henri et al (2001) observed that migratory
skin dendritic cells still express Langerin in the skin draining
lymph nodes. Here we extend these initial ¢ndings in that
Langerinþ cells were found in the T cell areas and were almost
always absent from B cell follicles. No Langerin expression
could be detected in the CD11c^ cells in the lymph nodes
underlining that Langerin is an exclusive marker for dendritic
cells. Further characterization of Langerin-expressing cells in the
lymph nodes revealed that these cells express high levels of MHC
class II as has been described for immigrated Langerhans cells in
the lymph nodes (Ruedl et al, 2000; Henri et al, 2001).
Furthermore, we demonstrate that substantial numbers of
Langerinþ cells were only found in skin draining lymph nodes,
whereas just few scattered cells were visible in the mesenteric
lymph nodes. This emphasizes the validity of Langerin as a
marker for epidermis-derived Langerhans cells. Weak Langerin
staining in the mesenteric lymph nodes was shown by Valladeau
et al (2002). They also described Langerinþ cells in epithelia of
the lung and the tonsils. Similar Langerin-expressing cells in the
epithelium of the gut (A. Kaser, personal communication) would
be a possible source for the Langerinþ cells in the mesenteric
lymphoid tissue.
To enhance the migration of Langerhans cells into the lymph
nodes we induced contact hypersensitivity reactions with TNCB
and observed an increase in Langerinþ cells in skin draining
lymph nodes. Other studies have shown that higher numbers of
dendritic cells can be found in the lymph nodes after application
of di¡erent contact sensitizers (Knight et al, 1985; Macatonia et al,
1986; Botham et al, 1987). Dendritic cells were identi¢ed by their
forward/side scatter pro¢les in the FACS, their expression of
MHC class II and other dendritic cell markers (CD11c), or by
the presence of sensitizing trackers such as FITC. These assays
did not allow an unequivocal discrimination between migratory
Langerhans cells and migratory dermal dendritic cells and their
relative contributions to sensitization. Additionally, the assays
may not always permit a clear-cut distinction between
migratory cells or lymph node-resident MHC class IIþ cells
because free FITC may di¡use through blood and lymph to
spleen and lymph nodes, respectively, where it would stain
resident dendritic cells (Pior et al, 1999; and own observations).
The MoAb against Langerin used here are tools to visualize
selectively immigrated Langerhans cells in the skin draining
lymph nodes and to study the relative contributions of
Langerhans cells to the induction of immune responses.
Immigrated Langerhans cells in the skin draining lymph
nodes are largely mature in the steady-state situation In
the steady-state, immature or partially mature Langerhans cells
are thought to carry self antigens to the lymph nodes thereby
maintaining peripheral tolerance (Steinman and Nussenzweig,
2002). Because of the lack of a Langerhans cell-speci¢c marker it
was not possible to de¢ne the maturation stage of immigrated
Langerhans cells in the steady-state vs the in£ammatory
situation. Here we show for the ¢rst time that Langerhans cells
tra⁄cking into the lymph node in the steady state already
express maturation marker 2A1, costimulatory molecules CD86
and CD40, and high levels of MHC class II. This is in some
contrast to recent observations by Geissmann et al (2002) who
reported that Langerinþ cells were largely immature in human
lymph nodes, albeit in a di¡erent situation, i.e., a chronic
in£ammation.We observed a small but consistent increase in the
expression of the CD86 and CD40 after application of contact
allergen, i.e., in response to in£ammation. In keeping with our
data, Ruedl et al (2001) showed that CD40þ/CD11cþ sorted
lymph node cells, possibly Langerhans cells, expressed CD80
and CD86 in the steady state and upregulated them after
application of a £uorescent tracer, i.e., in response to
in£ammation, too. In addition, the lymph node dendritic cells
still took up and processed antigens to some degree also
indicating an incomplete maturation state (Koch et al, 1995;
Ruedl et al, 2001).
In a mouse model of tolerance induction by injection of the
anti-DEC-205 MoAb coupled to a protein, tolerance was broken
after simultaneous injection of anti-CD40 MoAb, which
increased surface expression of CD86 and CD40 on CD11cþ
lymph node dendritic cells (Hawiger et al, 2001). Menges et al
(2002) demonstrated that partially mature dendritic cells
expressed lower levels of CD40 molecules and prevented the
development of experimental autoimmune encephalomyelitis in
mice in contrast to fully matured dendritic cells when
adoptively transferred.
Migration is closely linked to the maturation process.
Upregulation of CCR7, for instance, is a prerequisite for
migration to occur (Caux et al, 2002). Therefore, it is unlikely
that Langerhans cells arriving in the lymph node in the steady
state would still express an immature phenotype, even though
Geissmann et al (2002) recently suggested a way of uncoupling
migration (CCR7 expression) from maturation (CD83, CD86,
and CD208 expression). We observed here that, in response to
in£ammation, higher numbers of more mature Langerhans cells
arrive in the lymph node. This would increase the frequency of
encounters with T cells and thus the generation of immunity.
Thus, a combination of migration levels and the stage of
dendritic cell maturation might determine the outcome of the
response in the lymph node. This new antibody will allow to
gain further insights into these functional states of Langerhans
cells.
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